Physician profile
Vanessa J Walker
NPI 1225155773
$988.55
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $136 · 2021: $83.44 · 2022: $17.98 · 2023: $205 · 2024: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $380.94 | 2023-2024 | Dovato, Cabenuva |
| Astellas Pharma US INC | $101.34 | 2019-2021 | |
| Abbvie INC. | $71.43 | 2021-2022 | |
| Allergan, INC. | $70.52 | 2019-2020 | |
| Resmed Corp | $60.00 | 2019 | |
| Glaxosmithkline, LLC. | $54.56 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.96 | 2019 | |
| Inari Medical, INC. | $37.17 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $25.88 | 2019 | |
| Gilead Sciences, INC. | $24.37 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $22.67 | 2019 | |
| Shire North American Group INC | $20.80 | 2019 | |
| Greer Laboratories, INC. | $18.86 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.42 | 2019 | |
| Advanced Respiratory, INC | $15.22 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $14.41 | 2023 | Serostim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.